References
- Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020;58(7):1070–1076.
- Yang Y, Yang M, Shen C, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. MedRxiv. 2020 [cited 2020 Aug 4]. DOI:https://doi.org/10.1101/2020.02.11.20021493
- Xie J, Ding C, Li J, et al. Characteristics of patients with coronavirus disease (COVID‐19) confirmed using an IgM‐IgG antibody test. J Med Virol. 2020 [cited 2020 Aug 4]. DOI:https://doi.org/10.1002/jmv.25930
- Winter AK, Hegde ST. The important role of serology for COVID-19 control. Lancet Infect Dis. 2020;20(7):758–759.
- Yong SEF, Anderson DE, Wei WE, et al. Connecting clusters of COVID-19: an epidemiological and serological investigation. Lancet Infect Dis. 2020;20(7):809–815.
- Spiteri G, Fielding J, Diercke M, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European region, 24 January to 21 February 2020. Eurosurveillance. 2020;25(9):pii = 2000178.
- Sciensano. COVID-19 – wekelijks epidemiologisch bulletin van 8 mei 2020 [COVID-19 – weekly epidemiological bulletin of May 8th 2020] [ Internet]. 2020 May 8 [cited 2020 Aug 1]. Available from: https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200508%20-%20NL.pdf
- Streek H, Schulte B, Kuemmerer B, et al. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. MedRxiv. 2020 [cited 2020 Aug 1]. https://doi.org/10.1101/2020.05.04.20090076
- Inglesby TV. Public health measures and the reproduction number of SARS-CoV-2. JAMA. 2020;323(21):2186–2187.
- Van Elslande J, Houben E, Depypere M, et al. Diagnostic performance of 7 rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clin Microbiol Infect. 2020;26(8):1082–1087.
- Decru B, Van Elslande J, Weemaes M, et al. Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2. Clin Chem Lab Med. 2020 [cited 2020 Aug 4];58:e197–e199.
- Finoulst M. Kunnen we groepsimmuniteit tegen covid-19 alleen met een vaccin sneller bereiken [Can we achieve group immunity against COVID-19 faster only with a vaccine]? [ Internet] 2020 Apr 24 [Cited 2020 Aug 3]. Available from: https://www.gezondheidenwetenschap.be/gezondheid-in-de-media/kunnen-we-groepsimmuniteit-tegen-covid-19-alleen-met-een-vaccin-sneller-bereiken
- Steensels D, Oris E, Coninx L, et al. Hospital-wide SARS-CoV-2 antibody screening in 3056 staff in a tertiary center in Belgium. JAMA. 2020;324:195–197.
- Van Elslande J, Decru B, Jonckheere S, et al. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs. Clin Microbiol Infect. 2020 [cited 2020 Aug 4]. DOI:https://doi.org/10.1016/j.cmi.2020.07.038
- Long QX, Tang XJ, Shi QL, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200–1204.
- Van Kampen JJA, Van De Vijver DAMC, Fraaij PLA, et al. Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants. MedRxiv. [cited 2020 Sep 29]. DOI:https://doi.org/10.1101/2020.06.08.20125310
- To KK-W, Hung IF-N, Ip JD, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2020 [cited 2020 Sep 29]. DOI:https://doi.org/10.1093/cid/ciaa1275
- Van Elslande J, Vermeersch P, Vandervoort K, et al. Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain. Clin Infect Dis. 2020 [cited Sep 29]. DOI:https://doi.org/10.1093/cid/ciaa1330
- Raddad LJA, Chemaitelly H, Ayoub HH, et al. Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting. MedRxiv. 2020 [cited 2020 Sep 29]. DOI:https://doi.org/10.1101/2020.08.24.20179457
- Del Rio C, Malani PN. COVID-19—new insights on a rapidly changing epidemic. JAMA. 2020;323(14):1339–1340.
- “Immunity passports” in the context of COVID-19 [Internet]. 2020 Apr 24 [cited 2020 Aug 3]. Available from: https://www.who.int/news-room/commentaries/detail/immunity-passports-in-the-context-of-covid-19